EN DE
STOCK COMPARISON

Imed Infinity Medical-Limited Partnership vs Veeva Systems Inc Class A: Fair Value & Quality

Both stocks run through our valuation models. Here is how Imed Infinity Medical-Limited Partnership (IMED) and Veeva Systems Inc Class A (VEEV) compare, as of Aug 28, 2026.

As of Aug 28, 2026, Fair Value Calculator sees Veeva Systems Inc Class A as the less overvalued of the two: Imed Infinity Medical-Limited Partnership trades at ILS 0.89 versus a fair value of ILS 0.14 (-84%), while Veeva Systems Inc Class A trades at $282 versus $91.49 (-68%).
Imed Infinity Medical-Limited Partnership
IMED.TA · ILA · Health Care
-84%
upside to fair value
overvalued
PriceILS 0.89
Fair ValueILS 0.14
Quality56/100
Veeva Systems Inc Class A
VEEV · USD · Health Care
-68%
upside to fair value
overvalued
Price$282
Fair Value$91.49
Quality72/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Imed Infinity Medical-Limited PartnershipVeeva Systems Inc Class A
Valuation
P/E (TTM)33.6×
P/S (TTM)9.31×
0.33×P/B4.28×
EV/EBITDA28.7×
PEG0.85×
Dividend yield0.0%
Profitability
0%Net margin28%
Operating margin31%
-8%Return on equity14%
-8%Return on assets7%
Growth
-98%Revenue growth (YoY)16%
-18.2%Avg. growth/yr (3Y)14.0%
Avg. growth/yr (5Y)16.9%
Balance & size
$2MMarket cap$31B
weakGrowth qualityhealthy

Veeva Systems Inc Class A leads: 1 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Imed Infinity Medical-Limited Partnershipof which business quality 56 · market factors 28 Veeva Systems Inc Class Aof which business quality 72 · market factors 60
ProfitabilityMargins and returns on capital today
4
57
Quality GrowthAre margins and returns improving?
75
65
CashflowEarnings quality: real cash, not paper profit
50
93
Fin. StrengthBalance sheet, leverage, solvency risk
100
91
InvestmentDisciplined investing over empire-building
100
33
Low VolatilityCalm price path (market factor)
75
52
MomentumPrice trend over the last 3–12 months (market factor)
11
67
52W MomentumDistance to the 52-week high (market factor)
3
57
Net IssuanceBuybacks instead of dilution
21
72

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Imed Infinity Medical-Limited Partnership

Asset-BasedILS 0.62

1 of 1 models see the stock below the current price.

Veeva Systems Inc Class A

DCF Models$214
Earnings-Based$142
Dividend Discount$0.41
Multiples$93.60
Asset-Based$29.76
Growth DCF$200
Economic Profit$57.47
Growth Earnings$185

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Imed Infinity Medical-Limited Partnership
Bear ILS 0.09Fair Value ILS 0.14Bull ILS 0.18
ILS 0.89 = current price (white tick)
Veeva Systems Inc Class A
Bear $70.65Fair Value $91.49Bull $138
$282 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Imed Infinity Medical-Limited Partnership · Health Care

Quality score56 · above median
Fair value upside-84% · bottom 25%

Veeva Systems Inc Class A · Health Care

Quality score72 · Top 25%
Fair value upside-68% · bottom 25%

Bottom line

As of Aug 28, 2026, Fair Value Calculator sees Veeva Systems Inc Class A as the less overvalued of the two: Imed Infinity Medical-Limited Partnership trades at ILS 0.89 versus a fair value of ILS 0.14 (-84%), while Veeva Systems Inc Class A trades at $282 versus $91.49 (-68%).

Veeva Systems Inc Class A has the higher quality score (72/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.